// App-Quantinova.ai

71 : The predictive value of ARv7 expression in localized prostate caner treated with abiraterone, degarelix, and bicalutamide.

Researchers

Presenter

  • Niall Corcoran

Principal Investigators

  • Christopher Hovens

  • Nicholas Howard

  • Anthony Costello

  • Paul Ruljancich

  • Justin Peters

  • David Clarke

  • Jeremy Grummet

  • Phillip Dundee

  • John Pedersen

  • Andrew Ryan

  • Phillip Parente

  • Patricia Bugeja

  • Michael Kerger

Medical Centers

  • Department of Medical Oncology, Monash University, Faculty of Medicine, Nursing and Health Sciences, Eastern Health Clinical School, Box Hill, Australia

  • TissuPath, Melbourne, AustraliaAlfred Hospital, Prahan, AustraliaThe Epworth Centre, Victoria, Australia

  • Royal Melbourne Hospital, Parkville, Australia

  • University of Melbourne, Melbourne, Australia

  • Eastern Health and Epworth Eastern, Box Hill, Australia

  • Frankston Hospital, Frankston, Australia

  • Australian Prostate Cancer Centre Epworth, Richmond, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Bicalutamide

  • Prednisolone

  • CB-7598

  • Degarelix acetate

Outcome

  • N/A

Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved